These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32109910)

  • 1. In-vitro and in-vivo models for hepatitis B cure research.
    Allweiss L; Strick-Marchand H
    Curr Opin HIV AIDS; 2020 May; 15(3):173-179. PubMed ID: 32109910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-acting antivirals and viral RNA targeting for hepatitis B cure.
    French J; Locarnini S; Zoulim F
    Curr Opin HIV AIDS; 2020 May; 15(3):165-172. PubMed ID: 32209814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we cure hepatitis B virus with novel direct-acting antivirals?
    Martinez MG; Villeret F; Testoni B; Zoulim F
    Liver Int; 2020 Feb; 40 Suppl 1():27-34. PubMed ID: 32077597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure.
    Tsounis EP; Tourkochristou E; Mouzaki A; Triantos C
    World J Gastroenterol; 2021 Jun; 27(21):2727-2757. PubMed ID: 34135551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
    Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M
    J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B.
    Suresh M; Menne S
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of HBV infection.
    Dandri M; Petersen J
    Best Pract Res Clin Gastroenterol; 2017 Jun; 31(3):273-279. PubMed ID: 28774409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Gene Therapy Coming to Age.
    Soriano V
    AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
    Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
    J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical cure strategies for hepatitis B: direct-acting antiviral drugs].
    Huang AL; Yuan ZH; Nan YM; Yang DL; Guo JT; Li WH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):640-644. PubMed ID: 32911899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel viral and host targets to cure hepatitis B.
    Ko C; Michler T; Protzer U
    Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antivirals for the treatment of chronic hepatitis B.
    Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
    Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
    König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
    J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in new antivirals for chronic hepatitis B.
    Tang Y; Liang H; Zeng G; Shen S; Sun J
    Chin Med J (Engl); 2022 Feb; 135(5):571-583. PubMed ID: 35120358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.